Christopher J. Williams - 30 Sep 2022 Form 4 Insider Report for CLOROX CO /DE/ (CLX)

Role
Director
Signature
By Cheryl Brice, Attorney-in-Fact for
Issuer symbol
CLX
Transactions as of
30 Sep 2022
Net transactions value
$0
Form type
4
Filing time
04 Oct 2022, 16:27:00 UTC
Previous filing
29 Jul 2022
Next filing
04 Oct 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLX Deferred Stock Units Award $0 +101 +0.81% $0.000000 12,611 12 Aug 2022 Common Stock 101 Direct F1, F2, F3
transaction CLX Deferred Stock Units Award $0 +249 +2% $0.000000 12,860 30 Sep 2022 Common Stock 249 Direct F1, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1-for-1
F2 Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.
F3 The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.
F4 Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees.